Drug interactions for the following drug(s)
Applies to: Spiriva 18 MCG (tiotropium bromide 22.5 MCG) Inhalant Powder <> buPROPion HCl 150 MG 24HR Extended Release Oral Tablet
The metabolism of Tiotropium can be decreased when combined with Bupropion.
Applies to: butalbital 50 MG / acetaminophen 325 MG / caffeine 40 MG Oral Tablet <> buspirone hydrochloride 10 MG Oral Tablet
The risk or severity of adverse effects can be increased when Buspirone is combined with Butalbital.
Applies to: buspirone hydrochloride 10 MG Oral Tablet <> buPROPion HCl 150 MG 24HR Extended Release Oral Tablet
The metabolism of Buspirone can be decreased when combined with Bupropion.
Applies to: Methocarbamol 500 MG Oral Tablet <> butalbital 50 MG / acetaminophen 325 MG / caffeine 40 MG Oral Tablet
The risk or severity of adverse effects can be increased when Butalbital is combined with Methocarbamol.
Applies to: butalbital 50 MG / acetaminophen 325 MG / caffeine 40 MG Oral Tablet <> buPROPion HCl 150 MG 24HR Extended Release Oral Tablet
The metabolism of Acetaminophen can be decreased when combined with Bupropion.
Applies to: Methocarbamol 500 MG Oral Tablet <> buspirone hydrochloride 10 MG Oral Tablet
The risk or severity of adverse effects can be increased when Buspirone is combined with Methocarbamol.
Applies to: Spiriva 18 MCG (tiotropium bromide 22.5 MCG) Inhalant Powder <> Potassium Chloride 20 MEQ/L in Lactated Ringer's Solution with Dextrose 5 % Injectable Solution
Tiotropium may increase the ulcerogenic activities of Potassium Chloride.
Applies to: butalbital 50 MG / acetaminophen 325 MG / caffeine 40 MG Oral Tablet <> butalbital 50 MG / acetaminophen 325 MG / caffeine 40 MG Oral Tablet
The metabolism of Acetaminophen can be decreased when combined with Caffeine.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
Applies to: Spiriva 18 MCG (tiotropium bromide 22.5 MCG) Inhalant Powder <> buPROPion HCl 150 MG 24HR Extended Release Oral Tablet
Drug1 (rxcui = 580261, name = tiotropium 0.018 MG Inhalant Powder [Spiriva], tty = SBD). Drug2 (rxcui = 993541, name = 24 HR Bupropion Hydrochloride 150 MG Extended Release Oral Tablet, tty = SCD). Drug1 is resolved to Bupropion, Drug2 is resolved to tiotropium and interaction asserted in DrugBank between Bupropion and Tiotropium.
Applies to: butalbital 50 MG / acetaminophen 325 MG / caffeine 40 MG Oral Tablet <> buspirone hydrochloride 10 MG Oral Tablet
Drug1 (rxcui = 238154, name = Acetaminophen 325 MG / butalbital 50 MG / Caffeine 40 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 866083, name = buspirone hydrochloride 10 MG Oral Tablet, tty = SCD). Drug1 is resolved to Buspirone, Drug2 is resolved to butalbital and interaction asserted in DrugBank between Buspirone and Butalbital.
Applies to: buspirone hydrochloride 10 MG Oral Tablet <> buPROPion HCl 150 MG 24HR Extended Release Oral Tablet
Drug1 (rxcui = 866083, name = buspirone hydrochloride 10 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 993541, name = 24 HR Bupropion Hydrochloride 150 MG Extended Release Oral Tablet, tty = SCD). Drug1 is resolved to Buspirone, Drug2 is resolved to Bupropion and interaction asserted in DrugBank between Buspirone and Bupropion.
Applies to: Methocarbamol 500 MG Oral Tablet <> butalbital 50 MG / acetaminophen 325 MG / caffeine 40 MG Oral Tablet
Drug1 (rxcui = 197943, name = Methocarbamol 500 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 238154, name = Acetaminophen 325 MG / butalbital 50 MG / Caffeine 40 MG Oral Tablet, tty = SCD). Drug1 is resolved to Methocarbamol, Drug2 is resolved to butalbital and interaction asserted in DrugBank between Methocarbamol and Butalbital.
Applies to: butalbital 50 MG / acetaminophen 325 MG / caffeine 40 MG Oral Tablet <> buPROPion HCl 150 MG 24HR Extended Release Oral Tablet
Drug1 (rxcui = 238154, name = Acetaminophen 325 MG / butalbital 50 MG / Caffeine 40 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 993541, name = 24 HR Bupropion Hydrochloride 150 MG Extended Release Oral Tablet, tty = SCD). Drug1 is resolved to Acetaminophen, Drug2 is resolved to Bupropion and interaction asserted in DrugBank between Acetaminophen and Bupropion. Drug1 is resolved to Caffeine, Drug2 is resolved to Bupropion and interaction asserted in DrugBank between Caffeine and Bupropion.
Applies to: Methocarbamol 500 MG Oral Tablet <> buspirone hydrochloride 10 MG Oral Tablet
Drug1 (rxcui = 197943, name = Methocarbamol 500 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 866083, name = buspirone hydrochloride 10 MG Oral Tablet, tty = SCD). Drug1 is resolved to Buspirone, Drug2 is resolved to Methocarbamol and interaction asserted in DrugBank between Buspirone and Methocarbamol.
Applies to: Spiriva 18 MCG (tiotropium bromide 22.5 MCG) Inhalant Powder <> Potassium Chloride 20 MEQ/L in Lactated Ringer's Solution with Dextrose 5 % Injectable Solution
Drug1 (rxcui = 580261, name = tiotropium 0.018 MG Inhalant Powder [Spiriva], tty = SBD). Drug2 (rxcui = 847626, name = Calcium Chloride 0.0014 MEQ/ML / Glucose 50 MG/ML / Potassium Chloride 0.024 MEQ/ML / Sodium Chloride 0.103 MEQ/ML / Sodium Lactate 0.028 MEQ/ML Injectable Solution, tty = SCD). Drug1 is resolved to Potassium Chloride, Drug2 is resolved to tiotropium and interaction asserted in DrugBank between Potassium Chloride and Tiotropium.
Applies to: butalbital 50 MG / acetaminophen 325 MG / caffeine 40 MG Oral Tablet <> butalbital 50 MG / acetaminophen 325 MG / caffeine 40 MG Oral Tablet
Drug1 (rxcui = 238154, name = Acetaminophen 325 MG / butalbital 50 MG / Caffeine 40 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 238154, name = Acetaminophen 325 MG / butalbital 50 MG / Caffeine 40 MG Oral Tablet, tty = SCD). Drug1 is resolved to Acetaminophen, Drug2 is resolved to Caffeine and interaction asserted in DrugBank between Acetaminophen and Caffeine. Drug1 is resolved to Caffeine, Drug2 is resolved to Acetaminophen and interaction asserted in DrugBank between Caffeine and Acetaminophen.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.